Long-term Safety Data: The long-term safety profile, especially for newer agents like dual GLP-1/GIP receptor agonists, has yet to be fully established as they have been studied for a relatively short period
With the court battle between iDexis and SAHPRA set for June, and a broader section 23 declaration potentially on the horizon that could ban compounded GLP-1s outright, the coming weeks will be decisive for South Africa's compounding industry
Past research shows that people with type 2 diabetes have an increased risk for developing Alzheimers disease
Exploring the Nighttime Alternative While the morning is common, some individuals prefer taking their glutathione before bed
10.1016/j.biopha.2017.05.047 52 SharmaM.AroraK.SachdevR
However, current systematic conclusions about weight regain mostly came from the studies of bariatric surgery or behavioral interventions